FDA Ducks ViroPharma Suit Over Generics Guidelines
The U.S. Food and Drug Administration dodged a suit Friday brought by ViroPharma Inc. over its guidelines for testing whether generic drugs are equivalent to brand names....To view the full article, register now.
Already a subscriber? Click here to view full article